Veterinary Vaccines Market - Forecast(2019 - 2024)

Report Code: HCR 0058 Report Format: PDF + Excel Database

Veterinary Vaccines Market Overview:

According to the findings by the International Federation for Animal Health, 61% of animal diseases are zoonotic, meaning they have the potential to cause human pandemics.[1] Thus, veterinary vaccines are gaining traction as an imperative implementation for protecting animal health as well as public health as they effectively mimic the naturally acquired immunity. Increasing livestock population catering to feed the colossal non-vegetarian population coupled with the adoption of companion animals by the majority of households in developing as well as developed countries is disrupting the veterinary vaccines market. Technological advancements in vaccines, increasing consciousness concerning animal health, increasing investments by government bodies and associations, and augmented demand for animal based protein has driven this arcade to reach a staggering market size of $7.5 billion as of 2018, and the demand is estimated to increment at formidable compound annual growth rate (CAGR) of 8.2% during the forecast period of 2019 to 2025.

 

Veterinary Vaccines Market Outlook:

Economic Relief by Veterinary Vaccines-

Apart from being zoonotic, animal contagious diseases have rampant tendency to ubiquitously disrupt the economic stability of livestock production. As per the Federation of American Scientists, an epidemic of mad-cow disease in England in the 1990s cost $9 billion - $14 billion as compensation to agrarians, and additional $2.4 billion from loss of export marketplaces.[2]

As the livestock production accounts for nearly 40% of the global agricultural production value and is an integral source of nutrition for an estimated 9 billion population by 2050[3], veterinary vaccines market has found a major employer in this segment as animal diseases hamper efficient production and sources economic turbulence. Some of the transboundary animal diseases highly distressing the livestock sector commercial constancy are foot-and-mouth disease (FMD), H5N1 highly pathogenic avian influenza (HPAI), avian influenza (AI), lumpy skin disease (LSD), and Newcastle Disease.

 

After an acute analysis of the regional veterinary vaccines market share, North America was reckoned to be the dominating region securing the apex spot in terms of generating veterinary vaccines demand. This region accounts for 32% of the global veterinary vaccines market size as of 2018. The sheer affluence can be attributed to established vaccination programs and rise in ownership of pet animals. As per the National Pet Owners Survey conducted by the American Pet Products Association (APPA) 2017-2018, 68% of the U.S families own a pet with 60.2 million household housing a companion dog.[4] The United States Department of Agriculture (USDA) Center for Veterinary Biologics controls and authorize veterinary rabies vaccines. Some of the other canine vaccines include canine distemper, canine parvovirus, infectious canine hepatitis, adenovirus-2, leptospirosis, bordatella, canine parainfluenza virus, and Lyme disease. National Association of State Public Health Veterinarians, oversees vaccination and USDA-licensed vaccines. Thus, all these factor resonates the well-established veterinary healthcare facility disrupting the North America veterinary vaccines market growth.

 

There are several variants of vaccines designed for different kinds of diseases, such as veterinary viral vaccines, veterinary bacterial vaccines and veterinary parasite vaccines. Among these, live viral vaccines is the most dominant type flourishing at an application CAGR of 9.0% going through 2025. Live vaccines use an attenuated form of the germ that sources an infection. Owing to its peculiarities being identical to the natural contagion that they help in preventing, such vaccines create a resilient and enduring immune response. For instance, in 2017 Merck Animal Health pioneered the INNOVAX-ND-IBD, the first live vaccine curated with biotechnology that safeguards chickens from Newcastle Disease, transmittable bursal disease, and Marek’s ailment.

 

Veterinary Vaccines Market Trends and Growth Drivers:

Virus-like particle (VLP)-based vaccines- Some viral proteins can instinctively accumulate into biological nanoparticles, so-called ‘virus-like particles’. VLPs impersonates viral structures and are voluntarily acknowledged by the immune system, activating an enhanced immune reaction. Noticeable samples of VLP-based vaccines are some baculovirus/insect cell-expressed veterinary vaccines against Porcine circovirus 2 (PCV2), Ingelvac CircoFLEX® for example.


Modern developments in the study of virulence and pathogenicity amalgamated with operational molecular biological approaches have augmented the balanced design of vaccines, where virulence aspects have been controllably eradicated or functionally muted. This has headed to vaccines that uphold the useful properties of live vaccines while decreasing the threat for a possible reversion of virulence. A sample of this technology is a vaccine against Bovine viral diarrhoea virus (BVBD) recently introduced in the EU (Bovela).


Veterinary Vaccines Market Players Perspective:

Veterinary vaccines market is a flourishing arcade with players implementing biological and inorganic development policies to amplify their product offerings, reinforce their terrestrial spread, increase customer reach, increase substantial marketplace share and enhance veterinary vaccine development.

Some of the key players profiled in this report are Boehringer Ingelheim GmbH, Merck Animal Health, Zoetis Inc., Eli Lilly and Company, Bayer AG (Bayer Animal Health), Ceva Sant? Animale, Virbac, Biovac, Neogen Corporation, and ImmuCell Corporation.

 

December 2017, Prondil S.A., a developer and manufacturer of animal health vaccines for livestock was acquired by Merck Animal Health. This procurement aided Merck Animal Health to develop more progressive vaccines for a livestock animal in order to extend its market towards livestock sector.


Veterinary Vaccines Market Scope:

The base year of the study is 2018, with forecast done up to 2025. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. It also provides information on unit shipments. These provide the key market participants with the necessary business intelligence and help them understand the future of the veterinary vaccines market. The assessment includes the forecast, an overview of the competitive structure, the market shares of the competitors, as well as the market trends, market demands, market drivers, market challenges, and product analysis. The market drivers and restraints have been assessed to fathom their impact over the forecast period. This report further identifies the key opportunities for growth while also detailing the key challenges and possible threats. The key areas of focus include the various vaccines types in veterinary vaccines market, and their specific advantages.

 

Veterinary Vaccines Market Report: Industry Coverage

 

By Type: Veterinary Viral Vaccines, Veterinary Bacterial Vaccines, Veterinary Parasite Vaccines, Others

By Type of Disease: Bovine Vaccines, Feline Vaccines, Canine Vaccines, Poultry Vaccines, Equine Vaccines

By Geography: Americas, Europe, APAC, ROW

 

The Veterinary Vaccines Market report also analyzes the major geographic regions for the market as well as the major countries for the market in these regions. The regions and countries covered in the study include:

 

•           North America: The U.S., Canada, Mexico

•           South America: Brazil, Venezuela, Argentina, Ecuador, Peru, Colombia, Costa Rica

•           Europe: The U.K., Germany, Italy, France, The Netherlands, Belgium, Spain, Denmark

•           APAC: China, Japan, Australia, South Korea, India, Taiwan, Malaysia, Hong Kong

•           Middle East and Africa: Israel, South Africa, Saudi Arabia

 

Key Questions Addressed in the Veterinary Vaccines Market Report

1.         Is the market for the veterinary vaccines growing? How long will it continue to grow and at what rate?

2.         Which type of systems presents the major growth opportunities?

3.         Is there a possibility for change in the market structure over time? 

4.         Are additional developments needed for the existing product or services offerings or do the existing products meet the customer demands?

5.         Do the key vendors look for partnerships to expand their businesses with respect to geography or product?

6.         What are the short-term, long-term, and medium-term growth drivers for the market?

7.         What are the short-term, medium-term, and long-term challenges for the market?

8.         What are the short-term, medium-term, and long-term opportunities for the market

9.         Who are the top players/companies of the market?

10.       What are the recent innovations in the market?

11.       How many patents have been filed by the leading players?

12.       What are the types of patents filed by the leading players?

13.       What is our Vision 2030 for veterinary vaccines market?

 

A few focus points of this Research are given below:

•           Give a deep-dive analysis of the key operational strategies with focus on the corporate structure, R&D strategies, localization strategies, production capabilities, and sales performance of various companies

•           Provide an overview of the product portfolio, including product planning, development, and positioning

•           Discuss the role of technology companies in partnerships

•           Explore the regional sales activities

•           Analyze the market size and giving the forecast for current and future veterinary vaccines during the forecast 2019–2025

•           Analyze the competitive factors, competitors’ market shares, product capabilities, and supply chain structures.



[1] https://healthforanimals.org/component/attachments/attachments.html?task=attachment&id=34

[2] https://fas.org/biosecurity/education/dualuse-agriculture/1.-agroterrorism-and-foodsafety/economic-impact-of-crop-and-livestock-diseases.html

[3] http://www.fao.org/3/a-i5933e.pdf

[4] https://www.iii.org/fact-statistic/facts-statistics-pet-statistics

1. Veterinary Vaccines Market - Overview
1.1. Definitions and Scope
2. Veterinary Vaccines Market - Executive summary
2.1. Market Revenue, Market Size and Key Trends by Company
2.2. Key Trends by type of Application
2.3. Key Trends segmented by Geography
3. Veterinary Vaccines Market 
3.1. Comparative analysis
3.1.1. Product Benchmarking - Top 10 companies
3.1.2. Top 5 Financials Analysis
3.1.3. Market Value split by Top 10 companies
3.1.4. Patent Analysis - Top 10 companies
3.1.5. Pricing Analysis 
4. Veterinary Vaccines Market – Startup companies Scenario Premium
4.1. Top 10 startup company Analysis by
4.1.1. Investment
4.1.2. Revenue
4.1.3. Market Shares
4.1.4. Market Size and Application Analysis
4.1.5. Venture Capital and Funding Scenario
5. Veterinary Vaccines Market – Industry Market Entry Scenario Premium
5.1. Regulatory Framework Overview
5.2. New Business and Ease of Doing business index
5.3. Case studies of successful ventures
5.4. Customer Analysis – Top 10 companies
6. Veterinary Vaccines Market Forces
6.1. Drivers
6.2. Constraints
6.3. Challenges
6.4. Porters five force model
6.4.1. Bargaining power of suppliers
6.4.2. Bargaining powers of customers
6.4.3. Threat of new entrants
6.4.4. Rivalry among existing players
6.4.5. Threat of substitutes 
7. Veterinary Vaccines Market -Strategic analysis
7.1. Value chain analysis
7.2. Opportunities analysis
7.3. Product life cycle
7.4. Suppliers and distributors Market Share
8. Veterinary Vaccines Market – By Type (Market Size -$Million / $Billion)
8.1. Market Size and Market Share Analysis 
8.2. Application Revenue and Trend Research
8.3. Product Segment Analysis
8.3.1. Veterinary Viral Vaccines
  8.3.1.1. Live Viral Vaccines
  8.3.1.2. Inactivated Viral Vaccines
  8.3.1.3. DIVA Vaccines (Differentiating Infected from Vaccinated Animals)
  8.3.1.4. Molecularly Defined Subunit Vaccines
  8.3.1.5. Genetically Engineered Viral Vaccines
  8.3.1.8.3. Live Viral Vector Vaccines
  8.3.1.7. DNA Vaccines
   8.3.2. Veterinary Bacterial Vaccines
  8.3.2.1. Conventional Live Vaccines
  8.3.2.2. Conventional Inactivated Vaccines
  8.3.2.3. Gene-Deleted Vaccines
  8.3.2.4. Subunit Vaccines
   8.3.3. Veterinary Parasite Vaccines
  8.3.3.1. Protozoal Vaccines
  8.3.3.2. Subunit Protozoal Parasite Vaccines
  8.3.3.3. Helminth and Ectoparasite Vaccines
   8.3.4. Veterinary Vaccines for Infectious Diseases
  8.3.4.1. Allergy Vaccines
  8.3.4.2. Cancer Vaccines
9. Veterinary Vaccines Market – By Type of Disease (Market Size -$Million / $Billion)
9.1. Bovine Vaccines
9.1.1. Bovine Viral Diarrhea
9.1.2. Brucellosis
9.1.3. Foot and Mouth Disease
9.1.4. Bovine Clostridial Disease
9.1.5. Infectious Bovine Rhinotracheitis
9.2. Porcine Vaccines
9.2.1. Porcine Parvovirus
9.2.2. Porcine Reproductive Respiratory Syndrome
9.2.3. Porcine Circovirus II
9.2.4. Swine Influenza
9.2.5. Auzeszky’s Disease
9.2.6. Swine Pneumonia
9.3. Feline Vaccines
9.3.1. Feline Rabies
9.3.2. Feline Panleukopenia
9.3.3. Feline Leukemia
9.4. Canine Vaccines
9.4.1. Canine Rabies
9.4.2. Canine Distemper
9.4.3. Canine Parvovirus
9.5. Poultry Vaccines
9.5.1. Infectious Bronchitis
9.5.2. Gumboro Disease
9.5.3. Avian Influenza
9.5.4. Coccidiosis
9.5.5. Mycoplasma
9.5.6. Newcastle Disease
9.5.9. Marek’s Disease
9.6. Equine Vaccines
9.6.1. Strangles
9.6.2. Equine Influenza
9.6.3. Equine Encephalomyelitis
9.6.4. Tetanus
9.6.5. Equine Rhinopneumonitis
10. Veterinary Vaccines - By Geography (Market Size -$Million / $Billion)
10.1. Veterinary Vaccines Market - North America Segment Research
10.2. North America Market Research (Million / $Billion)
10.2.1. Segment type Size and Market Size Analysis 
10.2.2. Revenue and Trends
10.2.3. Application Revenue and Trends by type of Application
10.2.4. Company Revenue and Product Analysis
10.2.5. North America Product type and Application Market Size
10.2.5.1. U.S.
10.2.5.2. Canada 
10.2.5.3. Mexico 
10.2.5.4. Rest of North America
10.3. Veterinary Vaccines - South America Segment Research
10.4. South America Market Research (Market Size -$Million / $Billion)
10.4.1. Segment type Size and Market Size Analysis 
10.4.2. Revenue and Trends
10.4.3. Application Revenue and Trends by type of Application
10.4.4. Company Revenue and Product Analysis
10.4.5. South America Product type and Application Market Size
10.4.5.1. Brazil  
10.4.5.2. Venezuela
10.4.5.3. Argentina
10.4.5.4. Ecuador
10.4.5.5. Peru
10.4.5.6. Colombia 
10.4.5.7. Costa Rica
10.4.5.8. Rest of South America
10.5. Veterinary Vaccines - Europe Segment Research
10.6. Europe Market Research (Market Size -$Million / $Billion)
10.6.1. Segment type Size and Market Size Analysis 
10.6.2. Revenue and Trends
10.6.3. Application Revenue and Trends by type of Application
10.6.4. Company Revenue and Product Analysis
10.6.5. Europe Segment Product type and Application Market Size
10.6.5.1. U.K  
10.6.5.2. Germany 
10.6.5.3. Italy 
10.6.5.4. France
10.6.5.5. Netherlands
10.6.5.6. Belgium
10.6.5.7. Spain
10.6.5.8. Denmark
10.6.5.9. Rest of Europe
10.7. Veterinary Vaccines – APAC Segment Research
10.8. APAC Market Research (Market Size -$Million / $Billion)
10.8.1. Segment type Size and Market Size Analysis 
10.8.2. Revenue and Trends
10.8.3. Application Revenue and Trends by type of Application
10.8.4. Company Revenue and Product Analysis
10.8.5. APAC Segment – Product type and Application Market Size
10.8.5.1. China 
10.8.5.2. Australia
10.8.5.3. Japan 
10.8.5.4. South Korea
10.8.5.5. India
10.8.5.6. Taiwan
10.8.5.7. Malaysia
11. Veterinary Vaccines Market - Entropy
11.1. New product launches
11.2. M&A's, collaborations, JVs and partnerships
12. Veterinary Vaccines Market – Industry / Segment Competition landscape Premium
12.1. Market Share Analysis
12.1.1. Market Share by Country- Top companies
12.1.2. Market Share by Region- Top 10 companies
12.1.3. Market Share by type of Application – Top 10 companies
12.1.4. Market Share by type of Product / Product category- Top 10 companies
12.1.5. Market Share at global level- Top 10 companies
12.1.6. Best Practises for companies
13. Veterinary Vaccines Market – Key Company List by Country Premium
14. Veterinary Vaccines Market Company Analysis
14.1. Market Share, Company Revenue, Products, M&A, Developments
14.2. Zoetis
14.3. Merck Animal Health
14.4. Ceva Animal Health
14.5. Boehringer Ingelheim
14.6. Heska Corporation
14.7. Company 6
14.8. Company 7
14.9. Company 8
14.10. Company 9
14.10. Company 10 and more
"*Financials would be provided on a best efforts basis for private companies"
15. Veterinary Vaccines Market -Appendix
15.1. Abbreviations
15.2. Sources
16. Veterinary Vaccines Market -Methodology Premium
16.1. Research Methodology
16.1.1. Company Expert Interviews
16.1.2. Industry Databases
16.1.3. Associations
16.1.4. Company News
16.1.5. Company Annual Reports
16.1.6. Application Trends
16.1.7. New Products and Product database
16.1.8. Company Transcripts
16.1.9. R&D Trends
16.1.10. Key Opinion Leaders Interviews
16.1.10. Supply and Demand Trends
List of Tables:
Table1: Veterinary Vaccines Market Overview 2019-2024
Table2: Veterinary Vaccines Market Leader Analysis 2018-2019 (US$)
Table3: Veterinary Vaccines Market Product Analysis 2018-2019 (US$)
Table4: Veterinary Vaccines Market End User Analysis 2018-2019 (US$)
Table5: Veterinary Vaccines Market Patent Analysis 2013-2018* (US$)
Table6: Veterinary Vaccines Market Financial Analysis 2018-2019 (US$)
Table7: Veterinary Vaccines Market Driver Analysis 2018-2019 (US$)
Table8: Veterinary Vaccines Market Challenges Analysis 2018-2019 (US$)
Table9: Veterinary Vaccines Market Constraint Analysis 2018-2019 (US$)
Table10: Veterinary Vaccines Market Supplier Bargaining Power Analysis 2018-2019 (US$)
Table11: Veterinary Vaccines Market Buyer Bargaining Power Analysis 2018-2019 (US$)
Table12: Veterinary Vaccines Market Threat of Substitutes Analysis 2018-2019 (US$)
Table13: Veterinary Vaccines Market Threat of New Entrants Analysis 2018-2019 (US$)
Table14: Veterinary Vaccines Market Degree of Competition Analysis 2018-2019 (US$)
Table15: Veterinary Vaccines Market Value Chain Analysis 2018-2019 (US$)
Table16: Veterinary Vaccines Market Pricing Analysis 2019-2024 (US$)
Table17: Veterinary Vaccines Market Opportunities Analysis 2019-2024 (US$)
Table18: Veterinary Vaccines Market Product Life Cycle Analysis 2019-2024 (US$)
Table19: Veterinary Vaccines Market Supplier Analysis 2018-2019 (US$)
Table20: Veterinary Vaccines Market Distributor Analysis 2018-2019 (US$)
Table21: Veterinary Vaccines Market Trend Analysis 2018-2019 (US$)
Table22: Veterinary Vaccines Market Size 2018 (US$)
Table23: Veterinary Vaccines Market Forecast Analysis 2019-2024 (US$)
Table24: Veterinary Vaccines Market Sales Forecast Analysis 2019-2024 (Units)
Table25: Veterinary Vaccines Market, Revenue & Volume,By Type, 2019-2024 ($)
Table26: Veterinary Vaccines Market By Type, Revenue & Volume,Veterinary Viral Vaccines, 2019-2024 ($)
Table27: Veterinary Vaccines Market By Type, Revenue & Volume,Live Viral Vaccines, 2019-2024 ($)
Table28: Veterinary Vaccines Market By Type, Revenue & Volume,Inactivated Viral Vaccines, 2019-2024 ($)
Table29: Veterinary Vaccines Market By Type, Revenue & Volume,DIVA Vaccines (Differentiating Infected from Vaccinated Animals), 2019-2024 ($)
Table30: Veterinary Vaccines Market By Type, Revenue & Volume,Genetically Engineered Viral Vaccines, 2019-2024 ($)
Table31: North America Veterinary Vaccines Market, Revenue & Volume,By Type, 2019-2024 ($)
Table32: South america Veterinary Vaccines Market, Revenue & Volume,By Type, 2019-2024 ($)
Table33: Europe Veterinary Vaccines Market, Revenue & Volume,By Type, 2019-2024 ($)
Table34: APAC Veterinary Vaccines Market, Revenue & Volume,By Type, 2019-2024 ($)
Table35: Middle East & Africa Veterinary Vaccines Market, Revenue & Volume,By Type, 2019-2024 ($)
Table36: Russia Veterinary Vaccines Market, Revenue & Volume,By Type, 2019-2024 ($)
Table37: Israel Veterinary Vaccines Market, Revenue & Volume,By Type, 2019-2024 ($)
Table38: Top Companies 2018 (US$)Veterinary Vaccines Market, Revenue & Volume,,
Table39: Product Launch 2018-2019Veterinary Vaccines Market, Revenue & Volume,,
Table40: Mergers & Acquistions 2018-2019Veterinary Vaccines Market, Revenue & Volume,,


List of Figures :

Figure 1: Overview of Veterinary Vaccines Market 2019-2024
Figure 2: Market Share Analysis for Veterinary Vaccines Market 2018 (US$)
Figure 3: Product Comparison in Veterinary Vaccines Market 2018-2019 (US$)
Figure 4: End User Profile for Veterinary Vaccines Market 2018-2019 (US$)
Figure 5: Patent Application and Grant in Veterinary Vaccines Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in Veterinary Vaccines Market 2018-2019 (US$)
Figure 7: Market Entry Strategy in Veterinary Vaccines Market 2018-2019
Figure 8: Ecosystem Analysis in Veterinary Vaccines Market 2018
Figure 9: Average Selling Price in Veterinary Vaccines Market 2019-2024
Figure 10: Top Opportunites in Veterinary Vaccines Market 2018-2019
Figure 11: Market Life Cycle Analysis in Veterinary Vaccines Market
Figure 12: GlobalBy TypeVeterinary Vaccines Market Revenue, 2019-2024 ($)
Figure 13: Global Veterinary Vaccines Market - By Geography
Figure 14: Global Veterinary Vaccines Market Value & Volume, By Geography, 2019-2024 ($) 
Figure 15: Global Veterinary Vaccines Market CAGR, By Geography, 2019-2024 (%)
Figure 16: North America Veterinary Vaccines Market Value & Volume, 2019-2024 ($)
Figure 17: US Veterinary Vaccines Market Value & Volume, 2019-2024 ($)
Figure 18: US GDP and Population, 2018-2019 ($)
Figure 19: US GDP – Composition of 2018, By Sector of Origin
Figure 20: US Export and Import Value & Volume, 2018-2019 ($)
Figure 21: Canada Veterinary Vaccines Market Value & Volume, 2019-2024 ($)
Figure 22: Canada GDP and Population, 2018-2019 ($)
Figure 23: Canada GDP – Composition of 2018, By Sector of Origin
Figure 24: Canada Export and Import Value & Volume, 2018-2019 ($)
Figure 25: Mexico Veterinary Vaccines Market Value & Volume, 2019-2024 ($)
Figure 26: Mexico GDP and Population, 2018-2019 ($)
Figure 27: Mexico GDP – Composition of 2018, By Sector of Origin
Figure 28: Mexico Export and Import Value & Volume, 2018-2019 ($)
Figure 29: South America Veterinary Vaccines Market Value & Volume, 2019-2024 ($)
Figure 30: Brazil Veterinary Vaccines Market Value & Volume, 2019-2024 ($)
Figure 31: Brazil GDP and Population, 2018-2019 ($)
Figure 32: Brazil GDP – Composition of 2018, By Sector of Origin
Figure 33: Brazil Export and Import Value & Volume, 2018-2019 ($)
Figure 34: Venezuela Veterinary Vaccines Market Value & Volume, 2019-2024 ($)
Figure 35: Venezuela GDP and Population, 2018-2019 ($)
Figure 36: Venezuela GDP – Composition of 2018, By Sector of Origin
Figure 37: Venezuela Export and Import Value & Volume, 2018-2019 ($)
Figure 38: Argentina Veterinary Vaccines Market Value & Volume, 2019-2024 ($)
Figure 39: Argentina GDP and Population, 2018-2019 ($)
Figure 40: Argentina GDP – Composition of 2018, By Sector of Origin
Figure 41: Argentina Export and Import Value & Volume, 2018-2019 ($)
Figure 42: Ecuador Veterinary Vaccines Market Value & Volume, 2019-2024 ($)
Figure 43: Ecuador GDP and Population, 2018-2019 ($)
Figure 44: Ecuador GDP – Composition of 2018, By Sector of Origin
Figure 45: Ecuador Export and Import Value & Volume, 2018-2019 ($)
Figure 46: Peru Veterinary Vaccines Market Value & Volume, 2019-2024 ($)
Figure 47: Peru GDP and Population, 2018-2019 ($)
Figure 48: Peru GDP – Composition of 2018, By Sector of Origin
Figure 49: Peru Export and Import Value & Volume, 2018-2019 ($)
Figure 50: Colombia Veterinary Vaccines Market Value & Volume, 2019-2024 ($)
Figure 51: Colombia GDP and Population, 2018-2019 ($)
Figure 52: Colombia GDP – Composition of 2018, By Sector of Origin
Figure 53: Colombia Export and Import Value & Volume, 2018-2019 ($)
Figure 54: Costa Rica Veterinary Vaccines Market Value & Volume, 2019-2024 ($)
Figure 55: Costa Rica GDP and Population, 2018-2019 ($)
Figure 56: Costa Rica GDP – Composition of 2018, By Sector of Origin
Figure 57: Costa Rica Export and Import Value & Volume, 2018-2019 ($)
Figure 58: Europe Veterinary Vaccines Market Value & Volume, 2019-2024 ($)
Figure 59: U.K Veterinary Vaccines Market Value & Volume, 2019-2024 ($)
Figure 60: U.K GDP and Population, 2018-2019 ($)
Figure 61: U.K GDP – Composition of 2018, By Sector of Origin
Figure 62: U.K Export and Import Value & Volume, 2018-2019 ($)
Figure 63: Germany Veterinary Vaccines Market Value & Volume, 2019-2024 ($)
Figure 64: Germany GDP and Population, 2018-2019 ($)
Figure 65: Germany GDP – Composition of 2018, By Sector of Origin
Figure 66: Germany Export and Import Value & Volume, 2018-2019 ($)
Figure 67: Italy Veterinary Vaccines Market Value & Volume, 2019-2024 ($)
Figure 68: Italy GDP and Population, 2018-2019 ($)
Figure 69: Italy GDP – Composition of 2018, By Sector of Origin
Figure 70: Italy Export and Import Value & Volume, 2018-2019 ($)
Figure 71: France Veterinary Vaccines Market Value & Volume, 2019-2024 ($)
Figure 72: France GDP and Population, 2018-2019 ($)
Figure 73: France GDP – Composition of 2018, By Sector of Origin
Figure 74: France Export and Import Value & Volume, 2018-2019 ($)
Figure 75: Netherlands Veterinary Vaccines Market Value & Volume, 2019-2024 ($)
Figure 76: Netherlands GDP and Population, 2018-2019 ($)
Figure 77: Netherlands GDP – Composition of 2018, By Sector of Origin
Figure 78: Netherlands Export and Import Value & Volume, 2018-2019 ($)
Figure 79: Belgium Veterinary Vaccines Market Value & Volume, 2019-2024 ($)
Figure 80: Belgium GDP and Population, 2018-2019 ($)
Figure 81: Belgium GDP – Composition of 2018, By Sector of Origin
Figure 82: Belgium Export and Import Value & Volume, 2018-2019 ($)
Figure 83: Spain Veterinary Vaccines Market Value & Volume, 2019-2024 ($)
Figure 84: Spain GDP and Population, 2018-2019 ($)
Figure 85: Spain GDP – Composition of 2018, By Sector of Origin
Figure 86: Spain Export and Import Value & Volume, 2018-2019 ($)
Figure 87: Denmark Veterinary Vaccines Market Value & Volume, 2019-2024 ($)
Figure 88: Denmark GDP and Population, 2018-2019 ($)
Figure 89: Denmark GDP – Composition of 2018, By Sector of Origin
Figure 90: Denmark Export and Import Value & Volume, 2018-2019 ($)
Figure 91: APAC Veterinary Vaccines Market Value & Volume, 2019-2024 ($)
Figure 92: China Veterinary Vaccines Market Value & Volume, 2019-2024
Figure 93: China GDP and Population, 2018-2019 ($)
Figure 94: China GDP – Composition of 2018, By Sector of Origin
Figure 95: China Export and Import Value & Volume, 2018-2019 ($)Veterinary Vaccines Market China Export and Import Value & Volume, 2018-2019 ($)
Figure 96: Australia Veterinary Vaccines Market Value & Volume, 2019-2024 ($)
Figure 97: Australia GDP and Population, 2018-2019 ($)
Figure 98: Australia GDP – Composition of 2018, By Sector of Origin
Figure 99: Australia Export and Import Value & Volume, 2018-2019 ($)
Figure 100: South Korea Veterinary Vaccines Market Value & Volume, 2019-2024 ($)
Figure 101: South Korea GDP and Population, 2018-2019 ($)
Figure 102: South Korea GDP – Composition of 2018, By Sector of Origin
Figure 103: South Korea Export and Import Value & Volume, 2018-2019 ($)
Figure 104: India Veterinary Vaccines Market Value & Volume, 2019-2024 ($)
Figure 105: India GDP and Population, 2018-2019 ($)
Figure 106: India GDP – Composition of 2018, By Sector of Origin
Figure 107: India Export and Import Value & Volume, 2018-2019 ($)
Figure 108: Taiwan Veterinary Vaccines Market Value & Volume, 2019-2024 ($)
Figure 109: Taiwan GDP and Population, 2018-2019 ($)
Figure 110: Taiwan GDP – Composition of 2018, By Sector of Origin
Figure 111: Taiwan Export and Import Value & Volume, 2018-2019 ($)
Figure 112: Malaysia Veterinary Vaccines Market Value & Volume, 2019-2024 ($)
Figure 113: Malaysia GDP and Population, 2018-2019 ($)
Figure 114: Malaysia GDP – Composition of 2018, By Sector of Origin
Figure 115: Malaysia Export and Import Value & Volume, 2018-2019 ($)
Figure 116: Hong Kong Veterinary Vaccines Market Value & Volume, 2019-2024 ($)
Figure 117: Hong Kong GDP and Population, 2018-2019 ($)
Figure 118: Hong Kong GDP – Composition of 2018, By Sector of Origin
Figure 119: Hong Kong Export and Import Value & Volume, 2018-2019 ($)
Figure 120: Middle East & Africa Veterinary Vaccines Market Middle East & Africa 3D Printing Market Value & Volume, 2019-2024 ($)
Figure 121: Russia Veterinary Vaccines Market Value & Volume, 2019-2024 ($)
Figure 122: Russia GDP and Population, 2018-2019 ($)
Figure 123: Russia GDP – Composition of 2018, By Sector of Origin
Figure 124: Russia Export and Import Value & Volume, 2018-2019 ($)
Figure 125: Israel Veterinary Vaccines Market Value & Volume, 2019-2024 ($)
Figure 126: Israel GDP and Population, 2018-2019 ($)
Figure 127: Israel GDP – Composition of 2018, By Sector of Origin
Figure 128: Israel Export and Import Value & Volume, 2018-2019 ($)
Figure 129: Entropy Share, By Strategies, 2018-2019* (%)Veterinary Vaccines Market 
Figure 130: Developments, 2018-2019*Veterinary Vaccines Market 
Figure 131: Company 1 Veterinary Vaccines Market Net Revenue, By Years, 2018-2019* ($)
Figure 132: Company 1 Veterinary Vaccines Market Net Revenue Share, By Business segments, 2018 (%)
Figure 133: Company 1 Veterinary Vaccines Market Net Sales Share, By Geography, 2018 (%)
Figure 134: Company 2 Veterinary Vaccines Market Net Revenue, By Years, 2018-2019* ($)
Figure 135: Company 2 Veterinary Vaccines Market Net Revenue Share, By Business segments, 2018 (%)
Figure 136: Company 2 Veterinary Vaccines Market Net Sales Share, By Geography, 2018 (%)
Figure 137: Company 3Veterinary Vaccines Market Net Revenue, By Years, 2018-2019* ($)
Figure 138: Company 3Veterinary Vaccines Market Net Revenue Share, By Business segments, 2018 (%)
Figure 139: Company 3Veterinary Vaccines Market Net Sales Share, By Geography, 2018 (%)
Figure 140: Company 4 Veterinary Vaccines Market Net Revenue, By Years, 2018-2019* ($)
Figure 141: Company 4 Veterinary Vaccines Market Net Revenue Share, By Business segments, 2018 (%)
Figure 142: Company 4 Veterinary Vaccines Market Net Sales Share, By Geography, 2018 (%)
Figure 143: Company 5 Veterinary Vaccines Market Net Revenue, By Years, 2018-2019* ($)
Figure 144: Company 5 Veterinary Vaccines Market Net Revenue Share, By Business segments, 2018 (%)
Figure 145: Company 5 Veterinary Vaccines Market Net Sales Share, By Geography, 2018 (%)
Figure 146: Company 6 Veterinary Vaccines Market Net Revenue, By Years, 2018-2019* ($)
Figure 147: Company 6 Veterinary Vaccines Market Net Revenue Share, By Business segments, 2018 (%)
Figure 148: Company 6 Veterinary Vaccines Market Net Sales Share, By Geography, 2018 (%)
Figure 149: Company 7 Veterinary Vaccines Market  Net Revenue, By Years, 2018-2019* ($)
Figure 150: Company 7 Veterinary Vaccines Market  Net Revenue Share, By Business segments, 2018 (%)
Figure 151: Company 7 Veterinary Vaccines Market  Net Sales Share, By Geography, 2018 (%)
Figure 152: Company 8 Veterinary Vaccines Market  Net Revenue, By Years, 2018-2019* ($)
Figure 153: Company 8 Veterinary Vaccines Market  Net Revenue Share, By Business segments, 2018 (%)
Figure 154: Company 8 Veterinary Vaccines Market  Net Sales Share, By Geography, 2018 (%)
Figure 155: Company 9 Veterinary Vaccines Market  Net Revenue, By Years, 2018-2019* ($)
Figure 156: Company 9 Veterinary Vaccines Market  Net Revenue Share, By Business segments, 2018 (%)
Figure 157: Company 9 Veterinary Vaccines Market  Net Sales Share, By Geography, 2018 (%)
Figure 158: Company 10 Veterinary Vaccines Market  Net Revenue, By Years, 2018-2019* ($)
Figure 159: Company 10 Veterinary Vaccines Market  Net Revenue Share, By Business segments, 2018 (%)
Figure 160: Company 10 Veterinary Vaccines Market  Net Sales Share, By Geography, 2018 (%)
Figure 161: Company 11 Veterinary Vaccines Market  Net Revenue, By Years, 2018-2019* ($)
Figure 162: Company 11 Veterinary Vaccines Market  Net Revenue Share, By Business segments, 2018 (%)
Figure 163: Company 11 Veterinary Vaccines Market  Net Sales Share, By Geography, 2018 (%)
Figure 164: Company 12 Veterinary Vaccines Market  Net Revenue, By Years, 2018-2019* ($)
Figure 165: Company 12 Veterinary Vaccines Market  Net Revenue Share, By Business segments, 2018 (%)
Figure 166: Company 12 Veterinary Vaccines Market  Net Sales Share, By Geography, 2018 (%)
Figure 167: Company 13Veterinary Vaccines Market  Net Revenue, By Years, 2018-2019* ($)
Figure 168: Company 13Veterinary Vaccines Market Net Revenue Share, By Business segments, 2018 (%)
Figure 169: Company 13Veterinary Vaccines Market  Net Sales Share, By Geography, 2018 (%)
Figure 170: Company 14 Veterinary Vaccines Market  Net Revenue, By Years, 2018-2019* ($)
Figure 171: Company 14 Veterinary Vaccines Market  Net Revenue Share, By Business segments, 2018 (%)
Figure 172: Company 14 Veterinary Vaccines Market  Net Sales Share, By Geography, 2018 (%)
Figure 173: Company 15 Veterinary Vaccines Market  Net Revenue, By Years, 2018-2019* ($)
Figure 174: Company 15 Veterinary Vaccines Market  Net Revenue Share, By Business segments, 2018 (%)
Figure 175: Company 15 Veterinary Vaccines Market  Net Sales Share, By Geography, 2018 (%)